Evidence map›Paper›PMID 24084369›Full record

ReviewSeminars in immunology2013

Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections.

Vincent C Tam

Abstract readReview
In one paragraph

Review in Seminars in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Targeting Angiogenesis via Resolution of Inflammation.Cold Spring Harbor perspectives in medicine · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. COVID-19 and cancer: start the resolution!Cancer metastasis reviews · 2022
    Review
  14. Metabolic Regulation of Macrophage Activation.Journal of innate immunity · 2022
    Review
  15. Article
  16. Frontiers in physiology · 2022
    Article
  17. Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases.Frontiers in cellular and infection microbiology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vincent C TamSeattle Biomedical Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98109, USA. Electronic address: vincent.tam@seattlebiomed.org.

Funding

NIAID NIH HHS HHSN272200800058C
6 · The paper itself

Abstract

Bioactive lipid mediators play crucial roles in promoting the induction and resolution of inflammation. Eicosanoids and other related unsaturated fatty acids have long been known to induce inflammation. These signaling molecules can modulate the circulatory system and stimulate immune cell infiltration into the site of infection. Recently, DHA- and EPA-derived metabolites have been discovered to promote the resolution of inflammation, an active process. Not only do these molecules stop the further infiltration of immune cells, they prompt non-phlogistic phagocytosis of apoptotic neutrophils, stimulating the tissue to return to homeostasis. After the rapid release of lipid precursors from the plasma membrane upon stimulation, families of enzymes in a complex network metabolize them to produce a large array of lipid metabolites. With current advances in mass spectrometry, the entire lipidome can be accurately quantified to assess the immune response upon microbial infection. In this review, we discuss the various lipid metabolism pathways in the context of the immune response to microbial pathogens, as well as their complex network interactions. With the advancement of mass spectrometry, these approaches have also been used to characterize the lipid mediator response of macrophages and neutrophils upon immune stimulation in vitro. Lastly, we describe the recent efforts to apply systems biology approaches to dissect the role of lipid mediators during bacterial and viral infections in vivo.

Indexed as

AnimalsDocosahexaenoic AcidsEicosapentaenoic AcidHomeostasisHumansInfectionsLipid MetabolismMacrophagesMass SpectrometryNeutrophilsSystems BiologyDocosahexaenoic AcidsEicosapentaenoic AcidAAAIM2-like receptorALRAnti-inflammatoryarachidonic acidBorrelia burgdorferiCFUcolony forming unitsCOXcyclooxygenaseCYP450cytochrome P450DDXs/DHXsDExD/H box proteinsDHAdiHETrEdiHOMEdihydroxy-eicosatrienoic acidsdihydroxy-octadecenoic acidsdocosahexaenoic acidsE. coliEETeicosapentaenoic acidelectrospray ionizationEPAEpOMEepoxy-eicosatrienoic acidsepoxy-octadecenoic acidsESIgas chromatography coupled with mass spectrometryGM–MSHDoHEHEPEhepoxilin A3/B3HETEhigh performace liquid chromatographyHODEHOTrEHPLCHXA(3)/B(3)hydrox-eicosapentaenoic acidshydroxy-docosahexaenoic acidhydroxy-eicosatetraenoic acidshydroxy-octadecadienoic acidshydroxy-octadecatrienoic acidsInfluenzainhibitor of kappa BIκBLC–MSleukotrieneLipid mediatorsLipidomic analysislipoxin A4/B4lipoxygenaseliquid chromatography coupled with mass spectrometryLOXLTLXA(4)/B(4)Lyme diseaseMass spectrometryMRMmultiple reaction monitoringNFκBNLRNOD-like receptornon-steroidal anti-inflammatory drugsNSAIDsnuclear factor kappa Boxo-octadecadienoic acidoxoODEPAFpattern recognition receptorsPD1Peritonitisperoxisome proliferator-activated receptorPGplatelet-activating factorPMNpolymorphonuclear cellsPPARProinflammatoryPro-resolutionprostaglandinprotectin D1PRRsRIG-I like receptorRLRSystems biologythromboxane A2/B2TLRTNFtoll-like receptortumor necrosis factorTXA(2)/B(2)UDPuridine 5′-diphosphate

Identifiers

PMID24084369
PMCPMC3885417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.